231 related articles for article (PubMed ID: 9885794)
1. Antipsychotic potential of CCK-based treatments: an assessment using the prepulse inhibition model of psychosis.
Feifel D; Reza T; Robeck S
Neuropsychopharmacology; 1999 Feb; 20(2):141-9. PubMed ID: 9885794
[TBL] [Abstract][Full Text] [Related]
2. SR146131, a cholecystokinin-A receptor agonist, antagonizes prepulse inhibition deficits produced by dizocilpine and DOI.
Shilling PD; Feifel D
Psychopharmacology (Berl); 2002 Nov; 164(3):285-93. PubMed ID: 12424552
[TBL] [Abstract][Full Text] [Related]
3. Startle and sensorimotor gating in rats lacking CCK-A receptors.
Feifel D; Priebe K; Shilling PD
Neuropsychopharmacology; 2001 Jun; 24(6):663-70. PubMed ID: 11331146
[TBL] [Abstract][Full Text] [Related]
4. The modulation of sensorimotor gating deficits by mesolimbic cholecystokinin.
Feifel D; Swerdlow NR
Neurosci Lett; 1997 Jun; 229(1):5-8. PubMed ID: 9224788
[TBL] [Abstract][Full Text] [Related]
5. Reversal of sensorimotor gating deficits in Brattleboro rats by acute administration of clozapine and a neurotensin agonist, but not haloperidol: a potential predictive model for novel antipsychotic effects.
Feifel D; Melendez G; Shilling PD
Neuropsychopharmacology; 2004 Apr; 29(4):731-8. PubMed ID: 14760394
[TBL] [Abstract][Full Text] [Related]
6. Opposite effects mediated by CCKA and CCKB receptors in behavioural and hormonal studies in rats.
Männistö PT; Lang A; Harro J; Peuranen E; Bradwejn J; Vasar E
Naunyn Schmiedebergs Arch Pharmacol; 1994 May; 349(5):478-84. PubMed ID: 8065461
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the antipsychotic profile of the preferential PDE10A inhibitor, papaverine.
Weber M; Breier M; Ko D; Thangaraj N; Marzan DE; Swerdlow NR
Psychopharmacology (Berl); 2009 May; 203(4):723-35. PubMed ID: 19066855
[TBL] [Abstract][Full Text] [Related]
8. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ
Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991
[TBL] [Abstract][Full Text] [Related]
9. "Early" and "late" effects of sustained haloperidol on apomorphine- and phencyclidine-induced sensorimotor gating deficits.
Martinez ZA; Oostwegel J; Geyer MA; Ellison GD; Swerdlow NR
Neuropsychopharmacology; 2000 Nov; 23(5):517-27. PubMed ID: 11027917
[TBL] [Abstract][Full Text] [Related]
10. The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the rat.
Stanhope KJ; Mirza NR; Bickerdike MJ; Bright JL; Harrington NR; Hesselink MB; Kennett GA; Lightowler S; Sheardown MJ; Syed R; Upton RL; Wadsworth G; Weiss SM; Wyatt A
J Pharmacol Exp Ther; 2001 Nov; 299(2):782-92. PubMed ID: 11602695
[TBL] [Abstract][Full Text] [Related]
11. Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity.
Galici R; Boggs JD; Miller KL; Bonaventure P; Atack JR
Behav Pharmacol; 2008 Mar; 19(2):153-9. PubMed ID: 18332680
[TBL] [Abstract][Full Text] [Related]
12. Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade.
Auclair AL; Kleven MS; Besnard J; Depoortère R; Newman-Tancredi A
Neuropsychopharmacology; 2006 Sep; 31(9):1900-9. PubMed ID: 16421514
[TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations.
Kõks S; Männistö PT; Bourin M; Shlik J; Vasar V; Vasar E
J Psychiatry Neurosci; 2000 Jan; 25(1):33-42. PubMed ID: 10721682
[TBL] [Abstract][Full Text] [Related]
14. Changes in motor activity and forebrain [propionyl-3H]propionylated-CCK-8 binding in mice after repeated administration of drugs affecting cholecystokinin receptors.
Vasar E; Stephenson JD; Meldrum BS
Eur J Pharmacol; 1991 Sep; 202(3):385-90. PubMed ID: 1748160
[TBL] [Abstract][Full Text] [Related]
15. Effects of topiramate on the prepulse inhibition of the acoustic startle in rats.
Frau R; Orrù M; Fà M; Casti A; Manunta M; Fais N; Mereu G; Gessa G; Bortolato M
Neuropsychopharmacology; 2007 Feb; 32(2):320-31. PubMed ID: 16794573
[TBL] [Abstract][Full Text] [Related]
16. (+/-) Ketamine-induced prepulse inhibition deficits of an acoustic startle response in rats are not reversed by antipsychotics.
Cilia J; Hatcher P; Reavill C; Jones DN
J Psychopharmacol; 2007 May; 21(3):302-11. PubMed ID: 17591657
[TBL] [Abstract][Full Text] [Related]
17. Differential involvement of CCK-A and CCK-B receptors in the regulation of locomotor activity in the mouse.
Vasar E; Harro J; Lang A; Pôld A; Soosaar A
Psychopharmacology (Berl); 1991; 105(3):393-9. PubMed ID: 1798834
[TBL] [Abstract][Full Text] [Related]
18. Disruption of the prepulse inhibition of the startle reflex in vasopressin V1b receptor knockout mice: reversal by antipsychotic drugs.
Egashira N; Tanoue A; Higashihara F; Fuchigami H; Sano K; Mishima K; Fukue Y; Nagai H; Takano Y; Tsujimoto G; Stemmelin J; Griebel G; Iwasaki K; Ikeda T; Nishimura R; Fujiwara M
Neuropsychopharmacology; 2005 Nov; 30(11):1996-2005. PubMed ID: 15956991
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of antipsychotic and relative drugs using disruption of prepulse inhibition as an animal model for schizophrenia].
Suemaru K; Kohnomi S; Umeda K; Araki H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Jun; 28(3):121-6. PubMed ID: 18646597
[TBL] [Abstract][Full Text] [Related]
20. Ceruletide suppresses rotational behavior in lesioned rats via CCKA receptors.
Fujisawa M; Miyamoto O; Itano T; Tokuda M; Matsui H; Nagao S; Negi T; Hatase O
Eur J Pharmacol; 1993 Jul; 238(1):127-30. PubMed ID: 8405076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
